Psychotic Disorders Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Participants (Patients) 1. Diagnosis of a psychotic disorder by a clinician, which can include affective psychosis or non-affective psychoses 2. Followed and treated by a clinician of an outpatient clinic at the recruitment setting 3. Considered symptomatically stable and capable of interacting on the online platform and participating in focus groups and semi-structured interviews, as judged by their primary clinicians 5. Aged 18 years or older 6. Complete a screening for suicidal risk, assessed using the Ask Suicide-Screening Questions (ASQ) Toolkit (must indicate no to any of the questions 1 to 3, which assess for recent suicidal ideation) 7. Able to nominate an emergency contact to be eligible for the study Participants (Moderators and Other Team Members) Team members aged 18 years or older who have contributed to the adaptation, implementation, or evaluation of the intervention (e.g., clinical moderators, peer moderators, research assistants).
Exclusion criteria
Exclusion criteria: Participants (Patients) 1. Intellectual disability 2. Hospitalization at the time of recruitment 3. Inability to speak or read English or French 4. Individuals diagnosed with Antisocial personality disorder and/or Borderline personality disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Acceptability (perceived ease of use, perceived usefulness, and safety), assessed by the following: 1.1. HoryzonsCa Acceptability, Usability, Safety, and Impact Questionnaire (HC-AUSI-Q), a questionnaire and semi-structured interview that includes questions on perceived ease of use, perceived usefulness, enjoyment, and safety. This will be assessed at the 12-week follow-up (HoryzonsCa Final Interview) 1.2. Website usage analytics, in terms of frequency, duration and patterns of use over the study follow-up (i.e., 3 months) 2. Safety, assessed using: 2.1. Specific questions (i.e., I felt safe using HoryzonsCa, I felt like the information shared on HoryzonsCa was confidential) in the HC-AUSI-Q. This will be assessed at the 12-week follow-up 2.2. Any incidents and adverse events in relation to the use of the online system will be carefully monitored and quantified over the study follow-up (i.e., 3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Social functioning, measured at baseline and at 12-week follow-up using the following: 1.1. Personal and Social Performance Scale (PSP) 1.2. Employment and Education Status (average number of hours/week Employed or In School or In Vocational Training/Apprenticeship/Internship or Volunteering in the past 12 weeks) 2. Clinical benefits of HoryzonsCa, assessed at baseline and at 12-week follow-up using the following: 2.1. Positive and negative symptoms of psychosis, assessed using the 6-item Positive and Negative Syndrome Scale (PANSS-6) 2.2. Depression, assessed using the 9-item Patient Health Questionnaire (PHQ-9) 2.3. Anxiety, assessed using the 5-item Overall Anxiety Severity and Impairment Scale (OASIS) 2.4. Social support, assessed using the 12-item Multidimensional Scale of Perceived Social Support (MSPSS) 2.5. Loneliness, assessed using the 20-item UCLA Loneliness Scale (Version 3) 2.6. Self-esteem, assessed using the 20-item Self-Esteem Rating Scale Short Form, the 8-item Strengths Knowledge Scale (SKS), and the 14-item Strengths Use Scale (SUS) 2.7. Psychological well-being, assessed using the 14-item Warwick-Edinburgh Mental Well-Being Scale (WEMWBS) 3. The experience and process of adapting and implementing (including moderator training) HoryzonsCa for two age groups (18-35, 36-50) in a bilingual health services context from the perspectives of the research and moderation team, and the acceptability, safety, impact, and implementation of HoryzonsCa from the perspectives of participants (patients) will be assessed qualitatively through the following methods: 3.1. HoryzonsCa Meet-Up and Focus Groups with participants (patients) on an approximate monthly basis during implementation 3.2. HoryzonsCa Moderator Interview at the 12-week follow-up 3.3. Reflective Narratives from the Research and Moderation team at baseline, middle, and end of implementing the intervention 3.4. Field notes taken by team members upon completion of meetings with participants (i | — |
Countries
Canada